Charles A McWherter
5PUBLICATIONS
47CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.Cynthia Levy, Palak J Trivedi, Kris V Kowdley
|Apr 14, 2025
Single and Multiple Doses of Seladelpar Decrease Diurnal Markers of Bile Acid Synthesis in Mice.Edward E Cable, Jeffrey W Stebbins, Jeff D Johnson
|Dec 20, 2023
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis.Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield
|Oct 31, 2023
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.Marlyn J Mayo, John M Vierling, Christopher L Bowlus
|Jun 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein
Pageof 1
Frequent Collaborators
4 joint publications
Marlyn J Mayo
4 joint publications
Cynthia Levy
4 joint publications
Yun-Jung Choi
4 joint publications
Christopher L Bowlus
3 joint publications
Gideon M Hirschfield
3 joint publications
John M Vierling
3 joint publications
Andreas E Kremer
3 joint publications
Palak Trivedi
2 joint publications
Mitchell L Shiffman
2 joint publications
Stuart C Gordon
